financetom
Business
financetom
/
Business
/
Scorpius Holdings Signs Bioanalytical Services Contract With Clinical-Stage Biotech Firm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scorpius Holdings Signs Bioanalytical Services Contract With Clinical-Stage Biotech Firm
Oct 2, 2024 11:33 PM

10:39 AM EDT, 09/30/2024 (MT Newswires) -- Scorpius Holdings ( SCPX ) said Monday it signed a contract to provide a "publicly traded clinical-stage immuno-oncology company" with bioanalytical services.

Financial terms of the contract were not disclosed.

Shares of Scorpius Holdings ( SCPX ) were up 3.8% in recent trading.

Price: 0.76, Change: +0.03, Percent Change: +3.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Disney beats earnings forecasts on boost from streaming, US parks
Disney beats earnings forecasts on boost from streaming, US parks
May 26, 2025
* Disney+ gains 1.4 million users, taking total to 126 million * Domestic parks & experience operating income up 13% * Shares rise 5.8% in premarket trading (Updates share move in paragraph 2, adds bullet points) By Lisa Richwine and Dawn Chmielewski LOS ANGELES, May 7 (Reuters) - Walt Disney's ( DIS ) quarterly results topped Wall Street expectations on...
Teva Pharm first-quarter profit rise tops estimates
Teva Pharm first-quarter profit rise tops estimates
May 26, 2025
JERUSALEM (Reuters) -Teva Pharmaceutical Industries reported a slightly larger than expected rise in first-quarter profit, helped by strong sales gains in a trio of its branded drugs to treat migraines, Huntington's disease and schizophrenia. The world's largest generic drugmaker said on Wednesday it earned 52 cents per diluted share, excluding one-time items, in the January-March quarter, up from 48 cents...
BorgWarner lifts annual sales forecast on stronger foreign currency, tariff-driven recovery
BorgWarner lifts annual sales forecast on stronger foreign currency, tariff-driven recovery
May 26, 2025
May 7 (Reuters) - Auto parts supplier BorgWarner ( BWA ) on Wednesday raised its annual sales outlook, citing expectation of stronger foreign exchange and tariff-fueled customer recoveries. Shares of the company rose about 3% in premarket trade. U.S. President Donald Trump's vacillating tariff policy has disrupted companies across sectors, particularly in the import-heavy auto industry. Industry peer Magna plans...
Copyright 2023-2026 - www.financetom.com All Rights Reserved